Sumitomo Pharma Co., Ltd. (4506.T)
JPY 608.0
(19.69%)
JPY 608.0
(19.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 314.55 Billion JPY | -43.38% |
| 2022 | 555.54 Billion JPY | -0.8% |
| 2021 | 560.03 Billion JPY | 8.54% |
| 2020 | 515.95 Billion JPY | 6.88% |
| 2019 | 482.73 Billion JPY | 5.11% |
| 2018 | 459.26 Billion JPY | -1.62% |
| 2017 | 466.83 Billion JPY | 13.41% |
| 2016 | 411.64 Billion JPY | 2.09% |
| 2015 | 403.2 Billion JPY | 8.57% |
| 2014 | 371.37 Billion JPY | -4.21% |
| 2013 | 387.7 Billion JPY | 11.5% |
| 2012 | 347.73 Billion JPY | -0.76% |
| 2011 | 350.38 Billion JPY | -7.68% |
| 2010 | 379.52 Billion JPY | 28.09% |
| 2009 | 296.29 Billion JPY | 12.21% |
| 2008 | 264.06 Billion JPY | 0.03% |
| 2007 | 263.99 Billion JPY | 1.06% |
| 2006 | 261.21 Billion JPY | 6.28% |
| 2005 | 245.78 Billion JPY | 40.38% |
| 2004 | 175.08 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 90.07 Billion JPY | -0.66% |
| 2024 Q1 | 90.67 Billion JPY | 14.01% |
| 2023 Q3 | 82.38 Billion JPY | 7.06% |
| 2023 Q2 | 76.95 Billion JPY | 1.68% |
| 2023 Q1 | 75.68 Billion JPY | -20.56% |
| 2023 Q4 | 79.53 Billion JPY | -3.47% |
| 2023 FY | 314.55 Billion JPY | -43.38% |
| 2022 Q2 | 159.41 Billion JPY | -0.29% |
| 2022 Q1 | 159.87 Billion JPY | 24.94% |
| 2022 Q4 | 95.27 Billion JPY | -32.41% |
| 2022 FY | 555.54 Billion JPY | -0.8% |
| 2022 Q3 | 140.97 Billion JPY | -11.57% |
| 2021 Q4 | 127.96 Billion JPY | -7.5% |
| 2021 FY | 560.03 Billion JPY | 8.54% |
| 2021 Q1 | 131.19 Billion JPY | 8.26% |
| 2021 Q2 | 162.53 Billion JPY | 23.89% |
| 2021 Q3 | 138.34 Billion JPY | -14.88% |
| 2020 FY | 515.95 Billion JPY | 6.88% |
| 2020 Q1 | 133.85 Billion JPY | 6.48% |
| 2020 Q2 | 127.64 Billion JPY | -4.64% |
| 2020 Q3 | 133.26 Billion JPY | 4.41% |
| 2020 Q4 | 121.19 Billion JPY | -9.06% |
| 2019 FY | 482.73 Billion JPY | 5.11% |
| 2019 Q1 | 117.48 Billion JPY | 4.53% |
| 2019 Q2 | 113.11 Billion JPY | -3.72% |
| 2019 Q3 | 126.41 Billion JPY | 11.75% |
| 2019 Q4 | 125.71 Billion JPY | -0.55% |
| 2018 Q1 | 115.91 Billion JPY | 12.85% |
| 2018 FY | 459.26 Billion JPY | -1.62% |
| 2018 Q2 | 110.24 Billion JPY | -4.89% |
| 2018 Q3 | 120.71 Billion JPY | 9.5% |
| 2018 Q4 | 112.39 Billion JPY | -6.89% |
| 2017 FY | 466.83 Billion JPY | 13.41% |
| 2017 Q4 | 102.71 Billion JPY | -17.03% |
| 2017 Q3 | 123.8 Billion JPY | 7.48% |
| 2017 Q2 | 115.18 Billion JPY | -0.96% |
| 2017 Q1 | 116.29 Billion JPY | 9.57% |
| 2016 Q3 | 107.41 Billion JPY | 13.54% |
| 2016 Q1 | 103.49 Billion JPY | 4.88% |
| 2016 Q4 | 106.13 Billion JPY | -1.19% |
| 2016 FY | 411.64 Billion JPY | 2.09% |
| 2016 Q2 | 94.6 Billion JPY | -8.59% |
| 2015 FY | 403.2 Billion JPY | 8.57% |
| 2015 Q4 | 98.67 Billion JPY | -6.56% |
| 2015 Q3 | 105.6 Billion JPY | 4.76% |
| 2015 Q2 | 100.8 Billion JPY | 2.74% |
| 2015 Q1 | 98.11 Billion JPY | 6.39% |
| 2014 Q2 | 88.54 Billion JPY | -1.34% |
| 2014 Q3 | 100.84 Billion JPY | 13.9% |
| 2014 Q4 | 92.22 Billion JPY | -8.55% |
| 2014 FY | 371.37 Billion JPY | -4.21% |
| 2014 Q1 | 89.74 Billion JPY | -13.02% |
| 2013 Q3 | 103.12 Billion JPY | 12.36% |
| 2013 FY | 387.7 Billion JPY | 11.5% |
| 2013 Q2 | 91.77 Billion JPY | 2.39% |
| 2013 Q1 | 89.63 Billion JPY | 14.2% |
| 2013 Q4 | 103.17 Billion JPY | 0.06% |
| 2012 Q1 | 89.08 Billion JPY | 4.57% |
| 2012 Q2 | 89.65 Billion JPY | 0.64% |
| 2012 Q3 | 90.49 Billion JPY | 0.94% |
| 2012 Q4 | 78.48 Billion JPY | -13.27% |
| 2012 FY | 347.73 Billion JPY | -0.76% |
| 2011 Q1 | 94.79 Billion JPY | -3.96% |
| 2011 Q3 | 87.17 Billion JPY | 4.74% |
| 2011 Q4 | 85.19 Billion JPY | -2.27% |
| 2011 FY | 350.38 Billion JPY | -7.68% |
| 2011 Q2 | 83.22 Billion JPY | -12.2% |
| 2010 Q4 | 98.69 Billion JPY | 7.01% |
| 2010 FY | 379.52 Billion JPY | 28.09% |
| 2010 Q2 | 86.78 Billion JPY | -14.76% |
| 2010 Q1 | 101.81 Billion JPY | 10.05% |
| 2010 Q3 | 92.23 Billion JPY | 6.28% |
| 2009 FY | 296.29 Billion JPY | 12.21% |
| 2009 Q4 | 92.51 Billion JPY | 29.32% |
| 2009 Q3 | 71.54 Billion JPY | 8.13% |
| 2009 Q2 | 66.16 Billion JPY | 0.14% |
| 2009 Q1 | 66.07 Billion JPY | 6.35% |
| 2008 Q2 | 64.18 Billion JPY | 0.0% |
| 2008 Q4 | 62.12 Billion JPY | -8.09% |
| 2008 Q3 | 67.59 Billion JPY | 5.3% |
| 2008 FY | 264.06 Billion JPY | 0.03% |
| 2007 FY | 263.99 Billion JPY | 1.06% |
| 2006 FY | 261.21 Billion JPY | 6.28% |
| 2005 FY | 245.78 Billion JPY | 40.38% |
| 2004 FY | 175.08 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -406.152% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 92.623% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 27.701% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -3964.883% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -112.174% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -336.619% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 57.593% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -2435.531% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -121.979% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -205.737% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -467.733% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -923.019% |
| Tsumura & Co. | 150.84 Billion JPY | -108.531% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -316.198% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -475.713% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | -38.004% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -669.297% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -315.395% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -163.158% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -6141.23% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -570.771% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -5527.45% |
| MedRx Co., Ltd | 26 Million JPY | -1209738.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -2762.289% |
| Solasia Pharma K.K. | 617 Million JPY | -50881.848% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -400.546% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | -77.855% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -514623.786% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 78.699% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -1321.144% |